Effects of steroids on thrombogenic factors during unilateral TKA .
This report has been verified
by one or more authors of the
original publication.
Effects of steroids on thrombogenic markers in patients undergoing unilateral total knee arthroplasty: A prospective, double-blind, randomized controlled trial
J Orthop Res. 2015 Mar;33(3):412-6.30 patients scheduled for total knee arthroplasty were randomized to receive perioperative intravenous injections of corticosteroids or saline solution. The purpose of this study was to determine the effects of corticosteroid injections administered 2 hours prior to surgery on thrombogenic factors following total knee arthroplasty. Serum prothrombin fragment 1.2 (PF1.2) and plasmin-alpha-2-antiplasmin complex (PAP) levels, as well as blood loss, the incidence of venous thromboembolism, and wound complications were assessed throughout the study. Results indicated that patients who had received corticosteroids experienced significantly lower levels of PF1.2, an indicator of thrombin generation. However, there were no significant differences in any other outcomes measured between treatment or control groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
